Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

Recruiting Observational Study
Cardiac Failure Graft Rejection
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
Up to 18
Sex
Any
Study type
Observational
Participants needed
150 (estimated)
Sponsor
Inova Health Care Services · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
This study aims to discover circulating microRNAs (associated with drug doses and levels) that can be used to characterize the overall immune state in pediatric heart transplant patients and predict patients that will go on to develop infection and rejection. MicroRNAs (miRs) are small, non-coding RNA molecules that regulate gene expression and serve as molecular biomarkers found in the circulatio…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≤ 18 years at time of transplant listing * Subject is within 10-50 days post-orthotopic heart transplant at time of enrollment. * Planned follow-up at the transplant center for a minimum of one-year. * Caregiver able and willing to comply with the study visit schedule, stu…
Contacts

Palak Shah, MD

(703) 776-8000

palak.shah@inova.org

CONTACT

Stephanie Wolak, MPH

571-472-8558

stephanie.wolak@inova.org

CONTACT